Back
Reviva Pharmaceuticals Holdings Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
RVPH
Reviva Pharmaceuticals Holdings
Last Price:
$1.64
Seasonality Move:
-10.48%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--hereReviva Pharmaceuticals Holdings Stock Forecast
-
Is Reviva Pharmaceuticals Holdings Stock Undervalued?The current Reviva Pharmaceuticals Holdings [RVPH] share price is $1.34. The Score for RVPH is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
RVPH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Reviva Pharmaceuticals Holdings Stock Go Up Next Year?
Data Unavailable
Reviva Pharmaceuticals Holdings Stock Rating
Data Unavailable
Reviva Pharmaceuticals Holdings Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
revivapharma.com
52-Week Data
52-Week High:
5.67
52-Week Low:
0.60
Prediction Charts
Market Cap:
44.6M
Price in USD:
1.34
Volume:
4.4M
Beta:
-0.02
Technical Analysis
SMA50:
1.37
SMA100:
1.24
SMA200:
1.70
52-Wk Change:
-63.62%
Stock Predictions
-
Is Reviva Pharmaceuticals Holdings stock public?Yes, Reviva Pharmaceuticals Holdings is a publicly traded company.
-
What is the Reviva Pharmaceuticals Holdings stock quote today?The Reviva Pharmaceuticals Holdings stock price is 1.34 USD today.
-
How to buy Reviva Pharmaceuticals Holdings stock online?You can buy Reviva Pharmaceuticals Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-3 | 1.20 | 1.18 | 1.23 | 1.15 |
| Dec-4 | 1.20 | 1.25 | 1.26 | 1.15 |
| Dec-5 | 1.24 | 1.43 | 1.48 | 1.21 |
| Dec-6 | 1.51 | 1.65 | 1.68 | 1.45 |
| Dec-9 | 1.73 | 2.12 | 4.28 | 1.73 |
| Dec-10 | 2.40 | 2.52 | 2.99 | 2.21 |
| Dec-11 | 2.70 | 2.82 | 2.97 | 2.51 |
| Dec-12 | 2.76 | 2.77 | 2.95 | 2.62 |
| Dec-13 | 2.93 | 2.61 | 2.95 | 2.46 |
| Dec-16 | 2.67 | 2.30 | 2.74 | 2.25 |
| Dec-17 | 1.44 | 1.40 | 1.59 | 1.25 |
| Dec-18 | 1.44 | 1.44 | 1.75 | 1.40 |
| Dec-19 | 1.46 | 1.50 | 1.57 | 1.44 |
| Dec-20 | 1.50 | 1.34 | 1.51 | 1.23 |
Reviva Pharmaceuticals Holdings Earnings
Data Unavailable
Reviva Pharmaceuticals Holdings Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and an increase next year of $0.13 per share.
* Reviva Pharmaceuticals Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.